Discover the reality of companies and brands!

Find by name : 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
by country : United States, Great Britain, Canada, Australia [+]
by top manager : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
The world's largest companies
by thema, in 2008 [previous month +] :
Restructuring and labor conditions [+], Human rights and money laundering [+]
Pollution [+]
Financial delinquency [+], more frequent offshore locations, best paid top managers [+]
Influence:corruption/lobby [+]
Information: dubious practice [+]

Free and independant information on large corporations

Ranbaxy Laboratories Ltd

Headquarters : A-9-10 Industrial Area Sahibzada Ajit Singh Nagar Ropar 160055 Punjab India India

web www.ranbaxy.com analytics

Brands

name

click to compare prices

» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Ranbaxy Laboratories Ltd , group Daiichi Group and subsidiaries

Fraud 1 Offshore 1 Sales 4 Bn $.€ /year Profit 2 Bn $.€ /1998

[click on the rating for the method or on the number for the data]

shareholder

country

source

Daiichi Group

100

Bloomberg

» More shareholders of Ranbaxy Laboratories Ltd

year

business

source

2006

Seventh-largest generic drug manufacturer in the world.

Les Echos

» More business descriptions and market shares for Ranbaxy Laboratories Ltd.

country

address & contact : production type

incentive source

Ireland

Cashel : R&D

Offshore finance, secret bank account, tax haven, shell companies or free zone(s)

Les Echos

Malaysia

Joint-venture :

Nigeria

Joint-venture :

Romania

Terapia :

Les Echos

Thailand

Joint-venture :

» More locations of Ranbaxy Laboratories Ltd
» The World map of tax haven, secret accounts and shell companies

Executives (1)

Labor conditions

Environmental impact

Human impact

year

name

photo position; compensation

source

2006Mohan Singh, Malvinder

Chief Executive Officer;

» More executive salaries for Ranbaxy Laboratories Ltd
» Highest paid executives in 2007

Financials (1)

Lobbying & corruption

Subsidy

Advertising & marketing

year

financial misdemeanor

source

2005

Settled with the NHS over claims that it had helped operate a cartel on generic drugs. The company had been accused of working to artificially inflate the price of certain antibiotics. The company has paid £4,5m to settle the claims without admission of liability.

The Telegraph

» More financial data for Ranbaxy Laboratories Ltd
» Financial delinquency in 2007

year

financial misdemeanor

sales

income

assets

buyback

source

1 informations, access to subscribers

» More financial data for Ranbaxy Laboratories Ltd
» Financial delinquency in 2007